… At the time of drafting this article, the efficacy of COVID-19 mRNA vaccines against novel
mutant strains of SARS-CoV-2 remains unknown and is subject for further investigation. …

… of COVID-19 vaccines. Among these, the COVID-19 messenger RNA (mRNA) vaccine has
… -world data of COVID-19 mRNA vaccines as well as mRNA technology. Current challenges …

… vaccine candidates, which fall under four mRNA vaccine platforms: non-replicating linear
nucleoside-modified and unmodified mRNA… may hinder future vaccine development programs. …

… To estimate the benefits of mRNA vaccination against severe COVID-19, this study …
vaccination and hospitalization for COVID-19, as well as the association between prior vaccination …

… vaccine against laboratory-confirmed Covid-19 and safety. … syndrome coronavirus 2 (SARS-CoV-2)
infection and Covid-19 … Safe and effective prophylactic vaccines are urgently needed …

… This review paper aims to provide an overview of COVID-19 mRNA vaccines, describe
study findings for the COVID-19 vaccines by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-…

… the relative affordability of mRNA vaccines, access to COVID-19 mRNA vaccines has been
… to purchase vaccines. By April 2021, 4 months after the earliest vaccine authorizations, high-…

… mRNA vaccines already licensed for vaccination. In addition, we highlight the key strategies
in designing mRNA vaccines … vaccine development against COVID-19 and other pathogens. …

… compared with similar individuals at 22 to 42 days after vaccination. … vaccination with
mRNA COVID-19 vaccines and selected serious health outcomes 1 to 21 days after vaccination, …

… review article wrote that mRNA vaccines that “can … vaccinations, and alleviate healthcare
worker burden.” Much of this could rest on the success or failure of an mRNA COVID-19 vaccine…